Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Medical Genetics |
RCV000852375 | SCV000929971 | pathogenic | Polydactyly, postaxial, type A1 | 2019-02-01 | criteria provided, single submitter | research | |
OMIM | RCV001255655 | SCV001432216 | pathogenic | Polydactyly, postaxial, type a7 | 2020-09-11 | no assertion criteria provided | literature only | |
Prevention |
RCV003413586 | SCV004116883 | likely pathogenic | IQCE-related disorder | 2024-03-13 | no assertion criteria provided | clinical testing | The IQCE c.1350_1353delAGAG variant is predicted to result in a frameshift and premature protein termination (p.Glu452Aspfs*28). This variant has been reported in the compound heterozygous state along with IQCE c.895_904del10 in three siblings with postaxial polydactyly (Estrada-Cuzcano et al. 2020. PubMed ID: 31549751). This variant is reported in 0.073% of alleles in individuals of Latino descent in gnomAD). Frameshift variants in IQCE are expected to be pathogenic. This variant is interpreted as likely pathogenic. |